Acute Megacolon (Ogilvie Syndrome & Toxic Megacolon)

Epidemiology & Risk Factors

  • Ogilvie Syndrome (Acute Colonic Pseudo-obstruction [ACPO]):
    • Severe, non-mechanical colonic dilation in critically ill, elderly, or institutionalized pts.
    • Postoperative state (especially orthopedic, spinal, pelvic, or CABG surgery).
    • Severe trauma, sepsis, acute MI, or stroke.
    • Electrolyte abnormalities (hypokalemia, hypomagnesemia, hypocalcemia). c
    • Meds: Opiates, anticholinergics, CCBs, TCAs.
  • Toxic Megacolon:
    • Rapid, lethal dilation of the colon with severe systemic toxicity.
    • Prior hx of Ulcerative Colitis (UC) (most common) or Crohn disease.
    • Severe infectious colitis (most commonly Clostridioides difficile, CMV in immunocompromised, Salmonella, Shigella).
    • Triggers: Antimotility agents (e.g., loperamide), barium enema, or colonoscopy during active colitis flare.

Clinical Features

  • Ogilvie Syndrome:
    • Progressive, massive abdominal distension (hallmark).
    • Mild-to-moderate abdominal pain and obstipation/constipation (~40% still pass flatus/stool).
    • Abdomen is hypertympanic on percussion; bowel sounds are variable (usually hypoactive).
    • Minimal abdominal tenderness unless ischemia or perforation occurs.
  • Toxic Megacolon:
    • Profound systemic toxicity: High fever (>38°C/100.4°F), tachycardia (>120 bpm), hypotension/shock, altered mental status.
    • Bloody diarrhea (often severe, though stool frequency may suddenly decrease as colonic distension worsens).
    • Diffuse, severe abdominal pain with localized/generalized peritoneal signs (rebound, guarding).

Diagnosis

  • Ogilvie Syndrome:
    • Initial: Abdominal X-ray (KUB) showing diffuse colonic dilation (typically cecum and right colon) with gas in the rectum/sigmoid.
    • Confirmatory/Best: CT scan of abdomen/pelvis (with oral/IV contrast) to confirm diffuse colonic dilation and exclude mechanical obstruction (no transition point/mass).
    • Key Labs: BMP (rule out hypokalemia, hypomagnesemia), TFTs (exclude hypothyroidism).
    • Critical Threshold: Cecal diameter >10–12 cm indicates high risk of impending ischemia and rupture.
  • Toxic Megacolon:
    • Initial/Best: Abdominal X-ray (KUB) showing colonic dilation (typically transverse colon >6 cm) with loss of normal haustra and “thumbprinting” (mucosal edema).
    • Key Labs: CBC (marked leukocytosis with left shift, anemia), ESR/CRP (highly elevated), BMP, stool PCR for C. diff.
    • Contraindicated: Complete colonoscopy and barium enema are strictly contraindicated due to extreme risk of perforation.

Differential Diagnostics

  • Mechanical Large Bowel Obstruction (LBO):
    • Differentiating features: CT shows a clear transition point and a mechanical cause (e.g., neoplasm, stricture, fecal impaction).
  • Sigmoid/Cecal Volvulus:
    • Differentiating features: KUB shows pathognomonic “coffee bean” sign (sigmoid) or “bird’s beak” sign on gastrografin enema.
  • Paralytic Ileus:
    • Differentiating features: Uniform dilation of both the small and large intestines (stomach, small bowel, and colon) with minimal focal cecal dilation; typically resolves spontaneously within 3 days postoperatively. c
  • Ogilvie vs. Toxic Megacolon:
    • Differentiating features: Toxic megacolon presents with severe systemic toxic signs (fever, shock, marked leukocytosis) and underlying active mucosal inflammation/colitis, whereas Ogilvie presents in critically ill pts without active colitis or toxic signs unless perforation has occurred.

Management

  • Ogilvie Syndrome:
    1. First-line (Conservative):
      • Indicated if cecal diameter is <10–12 cm and no peritoneal signs.
      • NPO, NG tube for gastric decompression, and rectal tube.
      • Discontinue all offending meds (opiates, anticholinergics).
      • Aggressive correction of electrolytes (maintain K+ >4.0 mEq/L, Mg2+ >2.0 mg/dL).
      • Frequent mobilization/repositioning (prone or knee-chest position).
    2. Second-line (Pharmacologic):
      • Indicated if failed 24–48 hours of conservative tx OR cecal diameter >12 cm.
      • Neostigmine IV (acetylcholinesterase inhibitor).
      • Safety protocol: Requires continuous ECG and BP monitoring due to risk of severe bradycardia, bronchospasm, and salivation. Keep Atropine at bedside.
    3. Third-line (Endoscopic):
      • Endoscopic colonic decompression (colonoscopy without bowel prep/minimal air insufflation) if neostigmine is contraindicated (e.g., active bronchospasm, bradycardia, recent MI, or mechanical obstruction) or fails.
    4. Refractory/Emergent (Surgical):
      • Surg cecostomy or colectomy if there are signs of ischemia, gangrene, perforation, or peritonitis.
  • Toxic Megacolon:
    1. First-line (Medical Stabilization):
      • Aggressive IV fluid resuscitation, bowel rest (NPO), and NG tube decompression.
      • Broad-spectrum IV antibiotics (e.g., Ceftriaxone + Metronidazole, or Piperacillin-Tazobactam) to cover bowel flora and prevent translocation sepsis.
      • If secondary to IBD flare: High-dose IV Corticosteroids (Methylprednisolone).
      • If secondary to C. diff: Oral/rectal Vancomycin + IV Metronidazole.
    2. Second-line/Emergent (Surgical):
      • Subtotal colectomy with end ileostomy is the definitive tx.
      • Indications: Perforation, peritonitis, massive lower GI hemorrhage, or failure to clinically improve within 24–72 hours of intensive medical tx.

Complications

  • Colonic Perforation: Most common in the cecum (Ogilvie) or transverse colon (Toxic Megacolon); leads to high mortality.
  • Ischemia and Gangrene: Resulting from elevated intraluminal pressure compromising intramural blood flow.
  • Fecal Peritonitis & Sepsis: Can rapidly progress to septic shock and Multi-Organ Dysfunction Syndrome (MODS).
  • Abdominal Compartment Syndrome: Due to massive, tense colonic distension causing respiratory compromise and renal impairment.